Not investment advice. AI-generated analysis for educational purposes only. All trading involves risk of loss. Past performance does not guarantee future results. Full disclaimer

ABBV

HOLD

Health Care · S&P 500

Last updated: October 11, 2026 at 06:01 UTC

TRADEWISE AI SCORE

49

out of 100 — 6-factor composite

AI Debate Summary

4 AI agents (Research, Risk, Macro, Devil's Advocate) debated ABBV.

AI Debate from October 02, 2026 — data may be outdated. Get fresh analysis
ATLAS HOLD 38.0%

VOTE: HOLD CONFIDENCE: 38 --- **1. BULL CASE** AbbVie trades at a forward P/E of 16.08 with analyst consensus BUY and 7.28% upside to price target of $278.86. The company beat earnings in 2 of last 3

Read full analysis →

SENTINEL HOLD 38.0%

VOTE: HOLD CONFIDENCE: 38 --- **ASSESSMENT: NEUTRAL** This is a high-conviction HOLD, not a rejection of ABBV as an investment. The fundamentals are sound, but the setup lacks sufficient edge for en

Read full analysis →

HORIZON HOLD 52.0%

VOTE: HOLD CONFIDENCE: 52 --- ## 1. MACRO-STOCK TRANSMISSION **Current Macro Setup:** - Fed Funds Rate: 3.75% (elevated, continuing hawkish stance post-Sep 16 hike) - Inflation: 2.3% YoY (above 2% t

Read full analysis →

CONTRARIAN HOLD 42.0%

VOTE: HOLD CONFIDENCE: 42 ADVERSARIAL CLEARANCE: PASS --- ## 1. STRONGEST BULL CASE AbbVie completed the Apogee acquisition (Sept 2026), expanding its neuroscience franchise with a new Parkinson's th

Read full analysis →

CONSENSUS HOLD — 42% agreement

Full debate reasoning available on Pro tier.

Market Regime Context

CURRENT REGIME CHOPPY (Day 37)

TradeWise monitors 5 market states (CALM → CRISIS) using VIX, breadth, and tail risk signals. In CHOPPY regime, the system adjusts position limits, trailing stops, and cash reserves automatically. Learn more about regime detection.

Get real-time AI alerts for ABBV

4 AI agents debate every trade. 6-factor scoring. Regime-adaptive risk management. 14-day free trial, no credit card.

Start Free Trial →

Health Care Sector Peers

View all Health Care stocks →

Compare

Frequently Asked Questions

Is ABBV a buy right now?

Based on TradeWise's 6-factor AI model, ABBV currently scores 49/100, indicating a HOLD signal. This combines momentum, volume, trend structure, volatility, sector relative strength, and drawdown analysis. The current market regime is CHOPPY. Updated October 11, 2026 at 06:01 UTC.

What is the TradeWise AI score for ABBV?

ABBV has a TradeWise AI score of 49/100. Scores above 80 indicate STRONG BUY, 65-80 BUY, 45-65 HOLD, 30-45 WEAK, below 30 AVOID. Scores are updated daily based on the V56 momentum engine scanning all S&P 500 stocks.

How does ABBV compare to LLY?

Compare ABBV against sector peers using our head-to-head AI comparison tool. Each comparison shows 6-factor score breakdown, AI debate excerpts, and regime-adjusted analysis. See comparison →

Disclaimer: TradeWise provides AI-generated analysis for educational purposes only. This is not financial advice. Past performance does not guarantee future results. All investing involves risk of loss. Backtested results are hypothetical. Consult a qualified financial adviser before making investment decisions. Scores generated by the V56 momentum engine based on Jegadeesh & Titman (1993) momentum research and Barroso & Santa-Clara (2015) volatility targeting.